TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2022

Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study.

Rubi K Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.